PF-Atlas › Clinical Trials › NCT01465529
A Cross-over Study of OligoG in Subjects With Cystic Fibrosis. Fibrosis
OligoG CF-5/20 · Phase 1
Registry ID
NCT01465529
Phase
Phase 1
Status
Completed
Drug / intervention
OligoG CF-5/20
Sponsor
AlgiPharma AS
Start
2011-05
About this trial
OligoG CF-5/20 is evaluated in NCT01465529, a Phase 1 idiopathic pulmonary fibrosis study sponsored by AlgiPharma AS. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT01465529 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.